Dr. Nagy Habib

Biography

Nagy Habib is a Professor of Hepatobiliary Surgery at Imperial College London, specializing in liver, pancreas, and biliary system surgeries. He is an active surgeon who leads translational research in liver cancer treatment and has founded several spin-out companies to develop innovative treatments for patients. He pioneered the clinical trial use of adenovirus for liver cancer treatment and plasmid gene therapy using hydrodynamic gene delivery. Dr. Habib has been recognized as one of the top five leading hepato-pancreato-biliary surgeons globally for his innovative techniques, including bloodless liver resection and the development of the Habib 4X surgical device. He has made significant contributions to the field, including the performance of the first living-related liver transplant in Africa and the Middle East. He has received numerous accolades, such as the Takreem Laureate award in 2012. His work has been acknowledged at various international conferences, and he has been invited to speak on topics of regenerative medicine and surgical techniques. Dr. Habib has published extensively in the areas of gene therapy and stem cell therapy and is a member of the Faculty of Medicine at Imperial College London. He continues to contribute to the academic and medical community through his research and teaching.

Research Interests

Experience

Awards